A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
NCT: NCT04853251 · RECRUITING
Publicidade
ID NCTNCT04853251
EstadoRECRUITING
Data de início2021-12-14
Conclusão2027-08-31
SponsorGenentech, Inc. (INDUSTRY)
First posted
Last updated
Resumo breve
This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24W).
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.